CompaniesIzana Bioscience

Izana Bioscience

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

42

By Phase

PHASE2: 1

By Status

COMPLETED: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
Today
NCT03622658
Hover over trial bars to see details

Recent Trials

NCT03622658Lead Sponsor
Efficacy and Safety of Namilumab for Moderate-to-severe Axial Spondyloarthritis
PHASE2Completed
42 participants
Started: Sep 6, 2018 · Completed: Feb 4, 2020